Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients

Borderline Personality Disorder Clinical Trial

— EDUC-BPD  

Official title:

Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for Borderline Personality Disorder (BPD) Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05428462
• Other study ID #: RECHMPL21_0611
• Status: Completed
• Start date: January 1, 2021
• Est. completion date: September 1, 2021

Study information

• Verified date: May 2022
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

Description:

Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem.

A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis.

Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma.

Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 1, 2021
• Est. primary completion date: January 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with Borderline Personality disorder assessed according to SCID II

• Having attended the borderline education day

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Borderline Personality Disorder
• Personality Disorders

Intervention

Other:
• Psychoeducation day on borderline personality disorder
Transmission of latest knowledge on borderline personality disorder

Locations

Country	Name	City	State
France	University Hospital	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Comparison of internalized stigma of mental illnessillness	Comparison of internalized stigma of mental illness between pre-treatment	At immediate post-intervention
Primary	Comparison of internalized stigma of mentalillness	Comparison of internalized stigma of mental illness between pre-treatment	At 3 months post-intervention
Secondary	Depressive symptoms using the Beck Depression Inventory	Comparison of depressive symptoms between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Depressive symptoms using the Beck Depression Inventory	Comparison of depressive symptoms between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)	Comparison of the intensity of suicidal ideation between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)	Comparison of the intensity of suicidal ideation between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)	Comparison of psychological pain between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)	Comparison of psychological pain between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)	Comparison of the intensity of hopelessness between pre-treatment and post-intervention	At immediate post-intervention
Secondary	The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)	Comparison of the intensity of hopelessness between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	The intensity of optimism using analog visual scale	Comparison of the intensity of optimism between pre-treatment and post-intervention	At immediate post-intervention
Secondary	The intensity of optimism using analog visual scale	Comparison of the intensity of optimism between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction	Comparison of feeling of pleasure between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction	Comparison of feeling of pleasure between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction	Comparison of feeling of satisfaction between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction	Comparison of feeling of satisfaction between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Anxiety state using the State-Trait Inventory (STAI-State)	Comparison of the state of anxiety between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Anxiety state using the State-Trait Inventory (STAI-State)	Comparison of the state of anxiety between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Hopelessness using the Beck Hopelessness Scale (BHS)	Comparison of the hopelessness between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Hopelessness using the Beck Hopelessness Scale (BHS)	Comparison of the hopelessness between pre-treatment and 3 months post-intervention	At 3 months post-intervention
Secondary	Level of positive and negative affects using the PANAS Scale	Comparison of level of positive and negative affects between pre-treatment and post-intervention	At immediate post-intervention
Secondary	Level of positive and negative affects using the PANAS Scale	Comparison of level of positive and negative affects between pre-treatment and 3 months post-intervention	At 3 months post-intervention